HR6166119th CongressWALLET

Lowering Drug Costs for American Families Act

Sponsored By: Representative Pallone

Introduced

Summary

Expands federal drug price negotiation to 50 drugs while adding international price benchmarks and creating new national limits on prescription cost sharing, including a specific insulin cap and a standardized out-of-pocket framework.

Show full summary
  • Families and people with coverage will see a new standardized essential health benefits and out-of-pocket framework that requires child-only coverage and ties future limits to an annual premium adjustment. These rules apply to plan years beginning January 1, 2027.
  • People who use insulin must get at least one covered product for each insulin type and face cost sharing no greater than the lesser of $35 per 30-day supply or 25% of the negotiated price. Cost sharing under the cap counts toward deductibles and out-of-pocket maximums.
  • Insurers, employers, and drugmakers face a bigger negotiation program that grows the pool from 20 to 50 drugs and requires the Secretary to consider an average international market price using six comparator countries. The bill also adds Part B and Part D style commercial-market inflation rebates and increased reporting requirements.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

5 provisions identified: 2 benefits, 0 costs, 3 mixed.

Nationwide insulin cost cap

If enacted, many group and individual plans would have to cover selected insulin with no deductible and cap your cost for a 30-day supply. Your cost would be the lesser of $35 or 25% of the negotiated net price for a 30-day supply. Any payments you make under this cap would count toward your deductible and out-of-pocket maximum. Plans may exclude out-of-network insulin or charge more for it. This applies for plan years starting January 1, 2027.

New annual drug out-of-pocket limits

If enacted, individual and small-group plans (and many employer plans) would have new out-of-pocket rules starting for plan years on or after January 1, 2027. Prescription drug out-of-pocket limits would be $2,000 a year for self-only coverage and $4,000 for other-than-self-only coverage in 2027. These limits count deductibles, coinsurance, and copays, and they rise each year by a premium adjustment percentage. The bill would also stop the old PHSA cost-sharing rules for plan years beginning January 1, 2027.

Extend drug negotiation to private plans

If enacted, private group health plans and many individual market plans could be treated as having drug-price agreements when they cover a selected drug. Plans could opt out through a Secretary-specified process. When a plan is treated as having an agreement, the same program rules would apply and the plan must use the negotiated maximum fair price when figuring your cost-sharing. The government would publish which plans and issuers chose not to participate for each drug and price period.

Bigger negotiation pool and benchmarks

If enacted, the Drug Price Negotiation Program could select up to 50 drugs instead of 20. For negotiations starting January 1, 2028, the Secretary would have to consider the average price of the drug in Australia, Canada, France, Germany, Japan, and the United Kingdom. The bill would also repeal a recent statutory change so earlier law is restored for the program.

Change drug rebate and unit reporting

If enacted, Medicare Part B rebate rules would count 'billing units' instead of raw units and use reported data from two quarters earlier, excluding Medicaid-paid units. Part D rebate rules would use units reported for Average Manufacturer Price (AMP), exclude Medicaid and Part B rebate units, and, starting with plan year 2026, exclude units with 340B discounts. The bill also requires AMP reporting methods for manufacturers.

Sponsors & CoSponsors

Sponsor

Pallone

NJ • D

Cosponsors

  • Neal

    MA • D

    Sponsored 11/20/2025

  • Scott (VA)

    VA • D

    Sponsored 11/20/2025

  • Tonko

    NY • D

    Sponsored 11/21/2025

  • McClellan

    VA • D

    Sponsored 11/21/2025

  • Beatty

    OH • D

    Sponsored 11/21/2025

  • Del. Norton, Eleanor Holmes [D-DC-At Large]

    DC • D

    Sponsored 11/21/2025

  • Landsman

    OH • D

    Sponsored 11/21/2025

  • Mannion

    NY • D

    Sponsored 11/21/2025

  • Craig

    MN • D

    Sponsored 11/21/2025

  • Frankel, Lois

    FL • D

    Sponsored 11/21/2025

  • Matsui

    CA • D

    Sponsored 11/21/2025

  • Dingell

    MI • D

    Sponsored 11/21/2025

  • Wasserman Schultz

    FL • D

    Sponsored 11/21/2025

  • Thanedar

    MI • D

    Sponsored 11/21/2025

  • Goldman (NY)

    NY • D

    Sponsored 11/21/2025

  • Larson (CT)

    CT • D

    Sponsored 12/1/2025

  • Hoyer

    MD • D

    Sponsored 12/1/2025

  • Johnson (TX)

    TX • D

    Sponsored 12/1/2025

  • Simon

    CA • D

    Sponsored 12/1/2025

  • Riley (NY)

    NY • D

    Sponsored 12/1/2025

  • Costa

    CA • D

    Sponsored 12/1/2025

  • Clarke (NY)

    NY • D

    Sponsored 12/1/2025

  • Chu

    CA • D

    Sponsored 12/1/2025

  • Underwood

    IL • D

    Sponsored 12/1/2025

  • Dexter

    OR • D

    Sponsored 12/1/2025

  • Courtney

    CT • D

    Sponsored 12/1/2025

  • McIver

    NJ • D

    Sponsored 12/1/2025

  • Gillen

    NY • D

    Sponsored 12/1/2025

  • Schakowsky

    IL • D

    Sponsored 12/1/2025

  • Quigley

    IL • D

    Sponsored 12/2/2025

  • Omar

    MN • D

    Sponsored 12/2/2025

  • Deluzio

    PA • D

    Sponsored 12/3/2025

  • Bonamici

    OR • D

    Sponsored 12/3/2025

  • Fletcher

    TX • D

    Sponsored 12/5/2025

  • Carson

    IN • D

    Sponsored 12/9/2025

  • Garcia (CA)

    CA • D

    Sponsored 12/10/2025

  • Stansbury

    NM • D

    Sponsored 12/10/2025

  • Grijalva

    AZ • D

    Sponsored 12/17/2025

  • Lieu

    CA • D

    Sponsored 12/17/2025

  • Ansari

    AZ • D

    Sponsored 12/17/2025

  • Davids (KS)

    KS • D

    Sponsored 12/17/2025

  • Randall

    WA • D

    Sponsored 12/17/2025

  • DelBene

    WA • D

    Sponsored 12/18/2025

  • Waters

    CA • D

    Sponsored 12/18/2025

  • Krishnamoorthi

    IL • D

    Sponsored 12/18/2025

  • Friedman

    CA • D

    Sponsored 1/21/2026

  • Pocan

    WI • D

    Sponsored 2/4/2026

  • Vindman

    VA • D

    Sponsored 2/9/2026

  • McClain Delaney

    MD • D

    Sponsored 2/12/2026

  • Budzinski

    IL • D

    Sponsored 4/2/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in